Neuronetics, Inc. (STIM)
Last updated: 2026-10-24 10:26:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Neuronetics, Inc. (STIM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.11, with a market capitalization of $158.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $3.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$158.49M | |
$2.08 | |
$39.39 | |
$0.52 | |
$2.08 | |
575.04K | |
1.65M | |
-- | |
$3.44 | |
$0.80 | |
-- | |
-- |
Neuronetics, Inc. (STIM) Latest Closing Stock Price
Neuronetics, Inc. (STIM) last closed at $2.08 as of 2026-10-23 23:56:00, unchanged from the previous close of $2.08.
During the latest regular trading session, STIM traded between $0.52 and $39.39, with a volume of 575.04K shares. The closing price was near the lower end and near the middle of its 52-week range.
Neuronetics, Inc. (STIM) 7-Day Stock Price Change
Over the past seven days, Neuronetics, Inc. (STIM) moved from $1.95 to $2.11, representing a gain of 7.95% ($0.16).
The stock traded between $1.84 and $2.18 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 659.34 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
STIM 52-Week Price Position
Position in Range: 49.4%
STIM is currently trading at $2.11, placing it 49.4% of the way from its 52-week low of $0.80 to its 52-week high of $3.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Neuronetics, Inc. (STIM)?
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Neuronetics, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 658 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Neuronetics, Inc. (STIM) Stock on MEXC
Eligible investors can buy real shares of Neuronetics, Inc. (STIM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Neuronetics, Inc. (STIM) stock price today?
2.Is STIM stock going up or down today?
3.What is STIM pre-market price?
4.What is STIM after-hours price?
5.Is STIM stock trading now?
6.Where does STIM sit relative to its 52-week high and low?
7.What sector is Neuronetics, Inc. in?
8.What is Neuronetics, Inc.'s market capitalization and where is it listed?
9.How is STIM valued in terms of P/E ratio and EPS?
10.Does Neuronetics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
STIM Stock Calculator
Estimate the value between STIM shares and USD.
STIM Shares to USD
1.00 STIM shares = 2.105 USD
Calculations are estimates based on the latest available price and are for reference only.


